• Hui Zhuang

    Academician of Chinese Academy of Engineering (Virologist), epidemiological and microbiological expert, and Academician of Chinese Academy of Engineering (Virologist)


    Graduated from the 1st Medical College Moscow, former Soviet Union. Since September 1961, he had been teaching as a doctor in Zhongshan Medical University. In January 1963, he was transferred to Medical Department of Beijng University and since then he has been working there. He has been to State-owned reference laboratory of infections diseases (a concurrent WHO virus reference, and a biological safety and cooperative research center)  in Victoria State of Australia for three times. From May to August 1991, he held the post of visiting professor in the 1st Pathology Teaching and Research Section in Medical College of Japan University. In 2001, he was elected as academician of Department of medical and Health Sciences of Chinese Academy of Engineering. Now he is a professor in Department of Pathogenic Biology of Basic Medical College of Beijing University. Hui Zhuang successfully developed ELISA kit for hepatitis E virus IgG antibody and Hepatitis B surface antigen colloidal gold test strip. He has published more than 450 articles in academic journals domestic and abroad, and participated in compiling 5 monographs in English and more than 30 in Chinese, with 1 translated article. He has been presiding key projects in 7th, 8th and 9th five-year plan. He has participated in key projects in 10th five-year plan, 973 plan, 863 plan, major specialty project in national technology committee, introduction projects in national technology key projects, China-Japan and China-Belgium Cooperative Science Projects (Chinese hosts), etc.

     

    He is mainly engaged in researches on viral hepatitis. He firstly proved the existence of epidemiological and sporadic hepatitis E; summarized the clinical and epidemiological feature of Hepatitis E in China; put forward the hypothesis that pandemic or sporadic Hepatitis E might not correlate to genetic type but to epidemic factors; He also found that the antigen in the open reading frame 3 of Hepatitis E correlated mainly to acute antibodies, while antigen open reading frame 2 correlated closely to antibodies in the recovery. He firstly established in China the laboratory techniques for diagnosis and macaques model for Hepatitis E; He also exploited successfully “Diagnostic Kit for IgG Antibody to Hepatitis E Virus” and “Hepatitis B surface antigen colloidal gold test strip”. He has obtained three certificates for national new drugs. He has been awarded with two 2nd Prizes National Technology Advance, one 1st Prize of Technology Development from Health Department , one 1st Prize of Beijing Technology Development, one 1st Prize of Technology Development of Zhejiang Province and one American Patent. He has published more than 400 articles in academic journals domestic and abroad, including 30 admitted by SCI. There has been 250 quotation. He was elected as Academician of Chinese Academy of Engineering in 2001.

     

    Present positions:
    Professor and doctoral supervisor, Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center
    Member of the WHO Committee for the validation of polio eradication in West Pacific Region
    Member of the working group on hepatitis B control in West Pacific, WHO
    Public health specialist of World Hepatitis Union
    Discipline evaluation group of Academic Degree Committee of the State Council
    Member of the National Pharmacopoeia Commission
    Member of the leading group on hepatitis prevention of the Ministry of health
    Advisory Committee on viral hepatitis of the Ministry of health
    Member of China Standardization Committee of biological products
    Vice president of China Preventive Medicine Association
    Director of the Chinese Medical Association
    Honorary chairman and member of the liver disease society of Chinese Medical Association

     

    Part-time job:
    Chief editor of Chinese Journal of viral diseases, Chinese Journal of preventive medicine, and virology section of foreign medical Consultant.
    Honorary editor, chief editor, managing editor or member of editor board of more than ten journals, such as "Chinese Journal of Hepatology", "China public health", "Chinese Journal of epidemiology" "Journal of Chinese clinical and experimental pathology", " Journal of Liver disease in TCM integrated with Western medicine ", "Journal of China Biological products", "Chinese Journal of blood transfusion", “Journal of disease control” and Hepatology International
    Former post:
    Member of the WHO technical advisory panel on viral hepatitis
    Vice president of the International Association for hepatitis E
    Director of the Asia Pacific Regional Association for public health
    Expert group of National Postdoctoral Committee
    Member of the drug review committee of the Ministry of health
    Dean of Institute of public health, Beijing medical university; and deputy director of Beijing Institute of hepatitis
    Major honors:
    In December 1999, the Novel Drug Certificate was issued to "hepatitis B antigen colloidal gold kit" by the China drug administration;
    In August 1998, the Novel Drug Certificate was issued to the ELISA kit for hepatitis E virus IgG antibody by the China drug administration;
    In March 1999, the study of molecular biology, serology, diagnostic methods and sporadic hepatitis E of hepatitis E virus was awarded with the 2nd prize of national science and technology progression;
    In December 1993, "etiology and epidemiology of hepatitis E" was awarded the 2nd prize of national science and technology progression;
    In June 2004, the new coronavirus (N protein) assay kit (chemiluminescence) was given the new drug certificate issued by the China drug administration;
    In February 2003, "ImmunoreactiveantigensofhepatitisEvirus" was patented by the United States (US6514690B1);
    October 1998 " Molecular biology, laboratory diagnosis, animal infection and epidemiological research for Hepatitis G" won the 2nd prize of Ministry of education, science and technology progress (basic);
    In August 1997, "Research on molecular biology and serology of hepatitis E virus and sporadic hepatitis E" was awarded the 2nd prize of the Ministry of health for scientific and technological progress;
    In June 1992, "Research on etiology and epidemiology of hepatitis E virus" won the first prize issued by the Ministry of health for scientific and technological progression;
    In January 2005, "hepatitis E virus genetic type 4 and its molecular biology and infection of domestic animals" won the first prize of China Medical Science and technology award.
    In January 2005, "hepatitis E virus genetic type 4 and its molecular biology and infection of domestic animals" won the first prize of China Medical Science and technology award.

     


    Good at
  • Jiabang Sun

    Chief consultant, Professor 


    Graduted from Medical Deparmtent of Beijing Medical College in 1960. Now he is a professor, doctoral supervisor and chief consultant of Xuanwu Hospital of Capital Medical University, as well as member of standing committee of surgery society of Chinese medical society, member of Beijing General Surgical branch, the deputy head of national pancreatic surgery group, member of the ninth and tenth editorial board of Chinese Journal of surgery, and member of standing editor board of the Chinese Journal of general surgery and Journal of Hepatobiliary. In 1991, he obtained the special allowance of the State Council. He has been engaged in clinical and scientific researches on abdomen surgery for recent 40 years, and accumulated rich experience, especially in diagnosis and treatment of pancreatic cancer and severe pancreatitis. Researches on diagnosis/treatment of pancreatic cancer, percutaneous transhepatic biliary drainage, basic researches on obstructive jaundice, surgery for rectal cancer and diagnosis and treatment of severe pancreatitis have been awarded with scientific achievement award by Beijing City and Bureaus. He has participated in compiling monographs on clinical surgery, pancreatic surgery, laparoscopic surgery, common surgical diseases. He has published more than 170 articles. He is proficient in: he has profoundly studied diagnosis and treatment of pancreatic cancer and severe pancreatitis, in which diagnosis/treatment of pancreatic cancer, percutaneous transhepatic biliary drainage, basic researches on obstructive jaundice, surgery for rectal cancer and diagnosis and treatment of severe pancreatitis


    Good at
  • Xiangmei Chen

    Chief consultant, professor, doctoral supervisor, and Academician of Chinese Academy of Engineering


    Engaged for a long period in basic and clinical researches on chronic kidney diseases, especially the series innovative results that she has obtained in the field of IgA kidney diseases and senile kidney diseases. He has published more than 800 articles domestic and abroad, presided or attended more than 20 prospective multi-center clinical trials or the establishment of consensus. She has taken twice the positions of academic leader of “innovation research group” of National Nature Foundation and premier scientist for project of senile “973”. She has won four 2nd award of national technology progression, two 1st award of Beijing technology, two 1st award of Chinese Medical Technology, one award of technology by the Society of Chinese TCM integrated with Western Medicine, one 1st award and four 2nd awards of Army Technology Progression; she has 3 national patents. In 2006, she won “Heliang Heli Award for Technology development and nourishment. She has won Star of the first national middle-aged and youth medine, award of prominent experts” of the fourth chief department of PLA, and the technological star in the logistic department. She was among the first group of people elected as the first and second level in National hundred, thousands and 10-thousand personnel. She has won second prizes twice, and third prizes twice.

     


    Good at
  • Dayi Hu

    Headmaster of cardiovascular Institute of People's Hospital of Peking University 


    As the academician of International Eurasian Academy of Sciences, Headmaster of cardiovascular Institute of People's Hospital of Peking University, director of Cardiology Center, director of cardiology section of medical department of Peking University, managing director of Chinese Medical Association and Chinese Medical Doctor Association, chairman of Cardiology Branch of Chinese Medical Society, chairman of cardiovascular professional committee of Beijing Medical Association, member of executive committee of Beijing Medical Society, the first headmaster of cardiovascular physicians branch of Chinese Medical Doctor Association,  the first executive council member of evidence-based medicine professional committee of Chinese Medical Doctor Association, the vice president of the Fifth Council of Chinese Gerontological Society, vice president of Beijing Medical Association, membership of American College of Cardiology (FACC), a member of Heart Rhythm Society, specialist member of European Society of Cardiology (FESC). Member of international editorial board "American Journal of cardiac pacing and electrophysiology (PACE)", "Journal of Clinical Cardiology", "European Heart Disease Journal" and "Nature Cardiovascular Medicine" international ", and editor, deputy editor, editorial officers of multiple journals including Chinese Journal of Cardiology", "Medicine and Philosophy", "China Medicine Introduction", "China Cardiovascular Research", "Heart Disease Forum" and "Chinese New Drugs" .

     


    Good at
  • Defang Zhong

    Chinese Academy of Sciences, Shanghai Institute of Materia Medica researcher, director of Research Center for drug metabolism, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, director of the center for drug metabolism research


    Graduated from Shenyang College of pharmacy, chemistry and pharmacy. In January 1985, he received his master's degree in pharmaceutical analysis. In 1989, he received his Ph. D. degree in medicinal chemistry from University of Bonn in the Federal Republic of Germany, and spent 1990-1994 years in postdoctoral research at the pharmacist Center Laboratory in germany. Returned to China in July 1994, he served as professor and doctoral supervisor of Shenyang Pharmaceutical University and director of the laboratory of pharmacokinetics and pharmacokinetics of drugs. In 1995, he entered the National Education Commission trans century talent training program, and won the National Outstanding Youth Science Foundation in 1996. Academic part-time, members of the national pharmacopoeia commission, national drug review experts, Chinese Pharmacological Society, deputy director of drug metabolism Specialized Committee, Chinese Pharmaceutical Association, deputy director of Specialized Committee. Bioanalysis, Chinese Journal of new drugs, Journal of pharmaceutical science, Journal of pharmaceutical analysis, Journal of Chinese pharmacology and toxicology, Chinese Journal of clinical pharmacology and other editorial board members. Rich experience has been accumulated in LC-MS/MS quantitative analysis of biological samples and structural identification of drug metabolites. Responsible for the completion of more than 40 preclinical ADME trials of innovative drugs, and more than 200 studies on the bioequivalence and pharmacokinetics of the drugs. 40 doctoral students and 60 master students. There are more than 370 papers published in academic journals both at home and abroad, among which more than 170 journals are included in SCI. Published monographs and translations 4 times.

     

    Good at
  • Haitao Zhao

    Peking Union Medical College Hospital, chief physician of liver surgery


    Peking Union Medical College Hospital, chief physician at the Department of Hepatobiliary Surgery; benign and malignant disease diagnosis, surgical treatment and comprehensive treatment, research direction focused on hepatocellular carcinoma (HCC tumor molecular biology, genomics and transcriptomics) and clinical application (individualized treatment of malignant hepatobiliary tumor); has presided over the national key project of international cooperation, the National Natural Science Foundation (2), the Beijing capital development fund, the characteristics of the capital fund, Beijing natural fund and a number of fund, is the Ministry of science and technology, the National Natural Science foundation, Beijing Municipal Science and Technology Commission, Beijing Municipal Natural Science Foundation project evaluation experts, WJG journal, deputy editor of HPSN magazine, Scientific Report (Nature, Oncotarget, 10.1038/nm) BMC series Senior reviewer, such as SCI magazine. 40 papers were published by the first author or correspondent, including more than 30 SCI papers, with a total impact factor of over 160. The total citation was more than 1000, and 4 patents were applied. And in 2010-2011 were won by the Chinese Academy of Medical Sciences outstanding young scientists and technicians and the new century talents of the Ministry of education award.

     


    Good at
12